Sweden

 

NORDIC REGIONAL OFFICE

Gilead Sciences Sweden AB
Solna Gate
Hemvarnsgatan 9
171 54
Solna
Sweden

Phone: 46 8 5057 1800

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Gilead's operation in Sweden is responsible for sales and marketing support for Gilead’s products throughout the country.

Relationships with Charitable Organizations

Gilead provided support for the following charitable organizations in 2012, via unrestricted educational grants. The information is correct at the time of writing (March 2013). The information is subject to change and will be updated accordingly.

  • Grant Recipient
    Description of Activity
    Amount Funded SEK
  • HIV-Norden
    Financial support to attend the World AIDS congress in Washington
    50000
  • HIV-Norden
    Support the travel and accommodation cost for HIV & Your Sexlife meeting
    130000
  • HIV-Sverige
    Financial support to conduct 7-8 HIV educational meetings on 2012/2012
    30000
  • HIV-Sverige
    Support to attend the patient information evening in Copenhagen, Oct 23 2012
    1700
  • Noaks Ark
    Financial support to attend the World AIDS congress in Washington
    15000
  • Noaks Ark
    Financial support to attend the HIV in Europe congress to present poster on a test and treat clinic.
    19000
  • Noaks Ark
    Financial support to arrange information activities and campaigns on World Aids Day, Dec 1, 2012
    15000
  • Noaks Ark
    To establish Think Thanks in three priority regions, Stockholm, Malmö and Flen
    48000
  • Riksförbundet Cystisk Fibros
    To enable Riksförbundet Cystisk Fibros to arrange a Cystic Fibrosos Nordic Meeting
    25000
  • Riksförbundet Cystisk Fibros
    To enable Riksförbundet Cystisk Fibros to produce and publish a newsletter
    30000


This page is intended for visitors outside of the United States.